Broadcom's Future $100 Billion Custom Chip Business Is Your Sign to Buy Now

Broadcom's custom AI chip business grew 106% year over year to $8.4 billion in Q1, and management believes annual sales could exceed $100 billion by the end of next year. The article argues Broadcom is benefiting from hyperscaler demand for application-specific AI chips, with multiple customers' designs set to ramp through 2027. Overall tone is constructive on Broadcom's long-term revenue mix and AI growth trajectory.

Analysis

Broadcom’s edge is not just share gains in AI; it is the conversion of hyperscaler capex from a standardized GPU budget into a higher-margin, longer-duration co-design relationship. That shifts bargaining power: once a customer has sunk engineering time into a custom ASIC, switching costs rise materially, and the revenue stream tends to behave more like a multi-year platform annuity than a one-off hardware sale. The second-order winner is the networking/interconnect stack around these deployments, while the clearest loser is any incremental unit demand that would have gone to general-purpose accelerators at the margin.

The market is likely underpricing the timing asymmetry. The headline growth looks like a near-term step-up, but the real monetization likely lands in waves as design wins convert into tape-outs and then volume ramps over 12-24 months. That creates a setup where AVGO can beat estimates repeatedly even if end-demand is merely steady, because the mix shift into custom silicon and attached software/networking content can keep margins elevated longer than consensus expects.

The key risk is not demand collapsing; it is customer concentration and self-inflicted substitution. If a handful of hyperscalers successfully internalize more of the stack, Broadcom could eventually face pricing pressure on the next design cycle, especially if AI inference economics tighten and capex budgets get scrutinized. NVDA is not structurally broken, but its near-term incremental share of new AI spend could be capped if custom silicon continues to proliferate, making this more of a relative-share story than a total-addressable-market story.

Contrarian read: the bull case is probably directionally right but too linear. The consensus is extrapolating a clean ramp, while the more realistic path is lumpy revenue recognition, uneven customer adoption, and periodic digestion after large deployment phases. That argues for owning the higher-quality beneficiary on pullbacks, not chasing the stock after each AI headline, and for using volatility to express the view via structures rather than outright size.

Key Decisions for Investors

• Maintain a tactical long AVGO position into the next 2-3 earnings windows; add on 5-8% pullbacks, targeting a 12-18 month horizon where custom-chip ramps can re-rate the multiple alongside earnings revisions.
• Pair trade: long AVGO / short NVDA in modest size for 3-6 months to express relative share migration toward custom silicon; thesis breaks if GPU demand accelerates faster than expected or hyperscaler capex broadens materially.
• Buy AVGO call spreads 6-12 months out on pullbacks to reduce timing risk; structure for upside tied to repeated estimate revisions rather than a one-day catalyst.
• Avoid overexposure to pure-play accelerator names until hyperscaler budget commentary confirms that custom ASIC adoption is additive rather than substitutive; use any post-earnings strength in NVDA to trim tactical longs.
• Monitor hyperscaler capex guidance and design-win commentary as the key reversal signal; if spending growth decelerates or tape-out delays emerge, reduce AVGO exposure quickly because the stock is discounting a multi-quarter perfect execution path.